Tirzepatide peptide powder is a high-purity compound designed for research applications. With a molecular formula of C225H348N48O68 and a molecular weight of 4813, this white powder is packaged in vials for convenient laboratory use. Each vial contains 10mg, and the standard packaging is 10 vials per box.
Tirzepatide, also known as LY3298176, functions as a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. It is primarily utilized in studies related to type 2 diabetes, showcasing superior efficacy in glucose control and weight loss compared to other agents like Dulaglutide. Its mechanism involves mimicking natural GIP actions, contributing to reduced hyperglycemia in research settings.
Research indicates that tirzepatide may support weight loss in overweight subjects, with clinical trials demonstrating significant results. For instance, in the SURMOUNT-1 trial, weight reductions of up to 20.9% were observed over 72 weeks. This makes it a valuable compound for metabolic and pharmaceutical research.
This product is intended for research use only and is not for human consumption. Proper storage is essential: keep in a cold, dry, dark place, avoid repeated freezing and thawing, and minimize exposure to air and light. Aliquot according to experimental needs to maintain integrity.